This route should be reviewed as a co-amorphous solid complex candidate. The opportunity is scientific distinctiveness; the responsibility is honest confirmation and humidity-controlled handling.
Practical takeaway
The route is interesting when XRPD shows a broad amorphous halo, DSC shows a single Tg, FTIR shows interaction shifts, and HPLC stability remains controlled. It should stay in candidate-language until batch-level solid-form confirmation is complete.
Why this route is different from a simple blend
A simple physical mix can be easy to make but difficult to defend as a differentiated ingredient platform. A co-amorphous solid complex candidate gives the buyer a more meaningful technical story if the solid-form data are consistent and the stability file is disciplined.
The confirmation package
| Test | Successful pattern | Buyer meaning |
|---|---|---|
| XRPD | Broad amorphous halo rather than sharp crystalline peaks | Supports a co-amorphous candidate route |
| DSC | Single glass-transition event | Suggests one solid-form phase rather than a simple separated mix |
| FTIR | Interaction-related shifts | Supports interaction among DHB, citric acid, and creatine |
| HPLC stability | Controlled DHB retention, BBR formation, and creatinine | Connects solid-form design to practical storage review |
| KF water | Humidity trend under controlled packaging | Shows whether desiccant packaging is required |
Packaging is part of the product
The co-amorphous candidate route is more sensitive to moisture review than a conservative stable-route sample. Brands should include desiccant packaging, foil or high-barrier formats, and water trend monitoring in the development plan, not as an afterthought.
Best public positioning
Use careful language: co-amorphous solid complex candidate, solid-form development route, stability-screened DHB platform, and humidity-controlled sample review. This keeps the story scientifically interesting without overclaiming what still needs batch-level confirmation.
Recommended file path
Use the public article as a pre-read, then ask for the file set that matches the intended dosage form, market, and internal review process. The useful review package usually includes COA, specification, identity or source notes, stability or method summaries, formulation notes, and market-specific review comments where available.
Move from interest to sample review.
Request the DHB-Citric Acid-Creatine candidate file with XRPD, DSC, FTIR, HPLC, water, and packaging notes.
View the related product page or contact Nutrition BioTech for sample availability and dossier access.